The Association of Cytokines with Severe Dengue in Children

Background: Dengue virus infection is a major public health problem. A hypothesis put forward for severe dengue is the cytokine storm, a sudden increase in cytokines that induces vascular permeability. Previous studies and our recent meta-analysis showed that IL-6, IL-8, IFNγ, TNFα, VEGF-A and VCAM-1 are associated with dengue shock syndrome. Therefore, in this study we aim to validate the association of these cytokines with severe dengue. Methods & Findings: In a hospital based-case control study in Vietnam, children with dengue fever, other febrile illness and healthy controls were recruited. Dengue virus infection was confirmed by several diagnostic tests. Multiplex immunoassay using Luminex technology was used to measure cytokines simultaneously. A positive association with dengue shock syndrome was found for VCAM-1, whereas a negative association was found for IFNγ. Furthermore, multivariate logistic analysis also showed that VCAM-1 and IFNγ were independently correlated with dengue shock syndrome. Conclusion: IFNγ and VCAM-1 were associated with dengue shock syndrome, although their role in the severe dengue pathogenesis remains unclear. Additional studies are required to shed further light on the function of these cytokines in severe dengue.

[1]  S. Green,et al.  Markers of dengue disease severity. , 2010, Current topics in microbiology and immunology.

[2]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[3]  A. Nisalak,et al.  Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.

[4]  Yee‐Shin Lin,et al.  Correlation of IFN-inducible protein 10 levels in Sera with disease severity and clinical outcome of the dengue patients , 2008 .

[5]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[6]  A. Rothman,et al.  Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. , 2005, Cytokine.

[7]  T. Hien,et al.  Factors Associated with Dengue Shock Syndrome: A Systematic Review and Meta-Analysis , 2013, PLoS neglected tropical diseases.

[8]  S. Kalayanarooj,et al.  Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever , 2006, Journal of Virology.

[9]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[10]  K. Morita,et al.  Association of Mast Cell-Derived VEGF and Proteases in Dengue Shock Syndrome , 2012, PLoS neglected tropical diseases.

[11]  S. Yoksan,et al.  Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic Fever , 2012, The Pediatric infectious disease journal.

[12]  S. Kapoor,et al.  Elevated levels of IL‐8 in dengue hemorrhagic fever , 1998, Journal of medical virology.

[13]  Rosanna W. Peeling,et al.  Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.

[14]  Y. S. Lin,et al.  Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. , 2000, The American journal of tropical medicine and hygiene.

[15]  M. Juffrie,et al.  Inflammatory Mediators in Dengue Virus Infection: Circulating Interleukin-12 and Interferon-? , 2002 .

[16]  E. Azeredo,et al.  Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. , 2001, Immunobiology.

[17]  A. Rothman,et al.  Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. , 2006, Endothelium : journal of endothelial cell research.

[18]  J. V. D. van der Meer,et al.  Cytokine patterns during dengue shock syndrome. , 2003, European cytokine network.

[19]  B. Murgue,et al.  Plasma concentrations of sVCAM‐1 and severity of dengue infections , 2001, Journal of medical virology.

[20]  M. Guzmán,et al.  Apoptosis in tissues from fatal dengue shock syndrome. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  Y. Chan,et al.  Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[22]  E L Braga,et al.  Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. , 2001, Memorias do Instituto Oswaldo Cruz.

[23]  Y. Poovorawan,et al.  The role of vascular endothelial growth factor leading to vascular leakage in children with dengue virus infection , 2007, Annals of tropical paediatrics.

[24]  Fernando A Bozza,et al.  Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity , 2008, BMC infectious diseases.

[25]  T Kadhiravan,et al.  Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[26]  A. Nisalak,et al.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.

[27]  A. Osterhaus,et al.  Elevation of soluble VCAM‐1 plasma levels in children with acute dengue virus infection of varying severity , 2004, Journal of medical virology.

[28]  Albert D. M. E. Osterhaus,et al.  Dengue Virus Pathogenesis: an Integrated View , 2009, Clinical Microbiology Reviews.

[29]  G. Kuno,et al.  Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. , 1984, The American journal of tropical medicine and hygiene.

[30]  S. Kapoor,et al.  SHIFT FROM A TH1-TYPE RESPONSE TO TH2-TYPE IN DENGUE HAEMORRHAGIC FEVER , 1999 .

[31]  R. Lanciotti,et al.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.

[32]  S. Inoue,et al.  Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic Fever patient. , 2009, Japanese journal of infectious diseases.

[33]  日本熱帯医学会 Tropical medicine and health , 2004 .

[34]  D. Gubler,et al.  Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development , 2010, Current infectious disease reports.

[35]  A. Rothman,et al.  Increased Production of Interleukin-8 in Primary Human Monocytes and in Human Epithelial and Endothelial Cell Lines after Dengue Virus Challenge , 2002, Journal of Virology.

[36]  C. Ker,et al.  Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. , 2005, FEMS immunology and medical microbiology.

[37]  A. Nisalak,et al.  Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity , 1999, Journal of medical virology.

[38]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[39]  A. Mustafa,et al.  Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. , 2000, FEMS immunology and medical microbiology.

[40]  B. Wu-Hsieh,et al.  Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development , 2008, Journal of Virology.

[41]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[42]  S. Halstead,et al.  Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. , 2004, The Journal of infectious diseases.

[43]  A. Nisalak,et al.  Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. , 1999, The Journal of infectious diseases.

[44]  Trai-Ming Yeh,et al.  Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.

[45]  B. Seliger,et al.  Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. , 1998, Journal of immunology.